Amphastar Pharmaceuticals (AMPH) Amortizatization of Intangibles (2016 - 2026)

Amphastar Pharmaceuticals has reported Amortizatization of Intangibles over the past 13 years, most recently at $1.6 million for Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles fell 92.42% year-over-year to $1.6 million; the TTM value through Dec 2025 reached $6.5 million, down 73.68%, while the annual FY2025 figure was $6.5 million, 73.68% down from the prior year.
  • Amortizatization of Intangibles for Q4 2025 was $1.6 million at Amphastar Pharmaceuticals, up from -$7.6 million in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $21.7 million in Q4 2024 and troughed at -$7.6 million in Q3 2025.
  • A 5-year average of $1.8 million and a median of $972000.0 in 2023 define the central range for Amortizatization of Intangibles.
  • Biggest five-year swings in Amortizatization of Intangibles: crashed 1270.21% in 2022 and later surged 2151.87% in 2024.
  • Year by year, Amortizatization of Intangibles stood at $141000.0 in 2021, then crashed by 1270.21% to -$1.6 million in 2022, then skyrocketed by 158.42% to $964000.0 in 2023, then surged by 2151.87% to $21.7 million in 2024, then plummeted by 92.42% to $1.6 million in 2025.
  • Business Quant data shows Amortizatization of Intangibles for AMPH at $1.6 million in Q4 2025, -$7.6 million in Q3 2025, and $6.3 million in Q2 2025.